wells pharmacy semaglutide Compound Wells Road Pharmacy

Description

Reddy's submission on April 28, 2026, describing it as the first generic semaglutide authorized by Health Canada and the first to be approved in the G7 [Source: canada.ca/en/health-canada/news/2026/04/canada-becomes-the-first-g7-country-to-approve-a-generic-version-of-semaglutide.html]

Relative grip strength improved (strength normalized to body weight)

All anti obesity medications including semaglutide, tirzepatide, and liraglutide, may carry gastrointestinal adverse events such as abdominal pain, decreased appetite, and nausea, and they should be used under close medical supervision, particularly in individuals with a family medical history of thyroid cancer, or existing cardiovascular disease, chronic kidney disease, or risk of heart attack

How Semaglutide Works for Modest Weight Loss Targets Semaglutide reduces appetite by activating GLP-1 receptors in your brain that signal fullness and decrease hunger hormones like ghrelin